Tristel (TSTL:AIM) 356p Market cap: £172 million Cambridgeshire-based Tristel (TSTL:AIM) is a specialist in infection prevention whose products are used in the high-level disinfecting of medical equipment. While its primary focus is on acute treatments, which typically take place in major hospitals, the trend towards more medical procedures being outsourced to clinics and community healthcare...

Vodafone CFO buys sharesOutgoing Tristel boss sells sharesWeston family places AB Foods stakeLuka Mucic, chief financial officer of Newbury-based mobile network operator Vodafone (VOD), bought 510,000 shares at 76.15p for a total value of £388,365 on 4 June.Vodafone shares are down 1.1% year-to-date against a 5.6% gain for the FTSE 100.The purchase came less than a week after Vodafone...

'Quality investing' is the style pursued by the world's most famous investor Warren Buffett and Terry Smith, arguably the best-known British fund manager who runs the five-star Morningstar-rated Fundsmith Equity (B41YBW7) and consistently favours quality firms. Quality investing has generated strong long-run returns for its practitioners, including Buffett, but how do the leading fund managers...

LBG boss buys 341,929 sharesEveryman director tops up Tristel co-founder sells stockAlexander ?Solly? Solomou, chief executive of youth publisher LBG Media (LBG: AIM) bought 341,929 shares at an average of 73p for a total value of £248,753 on 18 April.Earlier in the week, the LADbible owner reported solid full-year results with group revenue rising 7.5% to £67.5 million.The company said...

US regulatory approval for high-level disinfectant Puts company in 'unique' competitive positionOpportunity could be worth 117p to 315p per shareInfection prevention specialist Tristel (TSTL:AIM) has secured US regulatory approval to sell its proprietary chlorine dioxide technology as a high level disinfectant in non-invasive ultrasound scans, sending the shares up 15% to 416.8p.The company...

- Shares gain as company returns to growth- US FDA clearance decision expected mid-2023- Parker Labs royalties renegotiated upwardsShares in infection prevention specialist Tristel (TSTL:AIM) jumped 6% to 330p on Monday as investors welcomed a return to pre-pandemic growth with underlying first-half revenues up 21% and adjusted pre-tax profit up 41% to £3.1 million.Prior to the pandemic and...

Tristel (TSTL:AIM) 747.4pLoss to date: 30%Original entry point: Buy at 492p, 16 December 2021Infection prevention and control company Tristel (TSTL:AIM) announced alongside a first-half update (21 Feb) it would exit non-chlorine dioxide based products catering to the animal health and life sciences sectors, incurring a non-cash charge of £2.4 million, which caused the shares to fall 20%.The...

Infection control and prevention specialist Tristel (TSTL) said first half revenues from continuing operations fell 7% to £13.6 million, but pre-tax profit dropped 58% after the company incurred a £2.4 million non-cash charge in relation to discontinued operations, causing the shares to drop 13% to 363p.The company's non-core chlorine-dioxide product range had been in decline for several...

There are many interesting businesses on the AIM market which fly under the radar as they do not get the same attention as their counterparts on the Main Market. Research coverage by analysts is thin, AIM stocks aren't discussed much in the media, and only fund managers with a mandate to look at small companies might even be aware of their existence.This means there is a big opportunity for...

Shares in infection prevention and contamination control specialist Tristel (TSTL:AIM) are trading just above pre-Covid-19 levels. This is despite the company's total addressable market increasingly significantly, driven by increased awareness and demand for infection prevention caused by the pandemic.There is significant pent-up demand for patient examinations which were put on hold during...

UK investors were in 'wait and see' mode ahead of a huge week for markets, with central banks in the UK, Europe, Japan and the US set to guide on the future path of interest rates.On Wednesday the US Federal Reserve is expected to announce it will accelerate 'tapering' or reducing its support for financial markets and to issue guidance on when it will raise rates, while on Thursday the Bank of...

Shares in supplier of infection control and prevention products Tristel (TSTL:AIM) plunged 17% to 557.4p after the firm admitted Covid-related delays to UK patient examinations had continued through the quarter to 31 March and showed little sign of reversing before its financial year-end in June.The company noted the departments and types of treatment which it serves were experiencing the...

UK shares made a hesitant start to the new week, with a strong pound holding back export-oriented shares and lower oil prices knocking the energy sector.Brent crude fell 1% to $65.4 a barrel and the pound gained 0.3% against the US dollar to $1.39.Overnight trading in Asia was mixed with Japan's Nikkei 225 gaining 0.3% and China's Composite index losing 0.95%.At 9am the FTSE 100 index of...

UK stocks gave up some of Friday's gains as markets in Asia softened and US futures also pointed down.At 9am the FTSE 100 index was trading down 70 points or 1% at 6,554 as government bond yields rose around the world, spurred by reflation hopes, and copper hit its highest price for nine years.Mining stocks were the principal gainers, accompanied by a handful of banks and travel and leisure...

The new venture capital trust (VCT) offer season is now in full swing where investors can apply for new shares and enjoy immediate tax benefits.Recent offers from Amati AIM VCT and Octopus AIM VCT have already closed, having hit their subscription target. Others are filling up quickly.Each year VCTs seem to attract money faster than the previous year, meaning interested investors need to act...

When a company makes a claim that its fabric coating kills all known bacteria and viruses including Covid-19 within 30 minutes and has a shelf-life of up to seven years, it tends to get attention.The Viroblock product from Swiss-based HeiQ Materials was originally developed as an antimicrobial for the Ebola crisis in 2013 and now it is seeing strong demand following the Covid-19...

Infection prevention and contamination control specialist Tristel (TSTL:AIM) reported full-year revenues up 21% to £31.7 million and pre-tax profit up 27% to £7.1 million, slightly ahead of the level indicated in July. The shares added 2.4% to 510p.Excluding acquisitions, the underlying growth in revenues was 11%, in line with the medium-term target of 10%-to-15%. The company has been...

London's FTSE 100 ended Friday's session in the red as a resurgence of Covid-19 cases in Europe, a growing number of outbreaks in the UK and a warning from Michel Barnier that a UK-EU Brexit trade deal 'seems unlikely' weighed on sentiment.These negatives overshadowed the UK's better than expected retail sales figures for July, while the FTSE may have fared worse but for a drop in sterling...

Britain's main stock index fell back into the red by lunchtime on Friday after an up and down morning, tumbling 0.46% to 5,985 by 12.50pm.The benchmark index had edged higher in mid-morning trading, despite skittishness caused by a resurgence of coronavirus cases in Europe, with investors initially buoyed by news that Pfizer could receive regulatory approval for its coronavirus vaccine as...

Infection prevention specialist Tristel (TSTL:AIM) has received approval from India's Central Drugs Standard Control Organisation (CDSCO) for its Duo high-level disinfectants for the decontamination of semi-critical medical devices . The announcement pushed the shares up 2% to 485p.Chief executive Paul Swinney said, 'The three Duo products provide Indian hospitals with an affordable and...